Abstract LB-147: Combination of the MEK inhibitor, pimasertib (MSC1936369B), and the PI3K/mTOR inhibitor, SAR245409, in patients with advanced solid tumors: Results of a phase Ib dose-escalation trial

Infante, Jeffrey R. ; Gandi, Leena ; Shapiro, Geoffrey ; Rizvi, Naiyer ; Burris, Howard A. ; Bendell, Johanna C. ; Baselga, José ; Hsu, Karl ; von Richter, Oliver ; Locatelli, Giuseppe ; Asatiani, Ekaterine ; Heist, Rebecca S.

Cancer research (Chicago, Ill.), 2013-04, Vol.73 (8_Supplement), p.LB-147-LB-147 [Periódico revisado por pares]

Texto completo disponível